Inzoomen: druk op uw toetsenbord op CtrlCommand + +
Uitzoomen: druk op uw toetsenbord op CtrlCommand + -
Gebruik knijpzoomen om eenvoudig in en uit te zoomen

SCIBMO study

Laatste wijziging: 24 januari 2022

Identification and characterization of newly found antibody biomarkers for spinal cord damage

 

Principal Investigator: Prof. Dr. Veerle Somers, Researcher: Ilse Palmers

 

The goal of this project is to determine the dual nature of the immune response after spinal cord injury. More specifically, characterize the different immune cells and immune mediators found in blood of patients with spinal cord injury, which are associated with the recovery processes or with secondary damage. This will result in a new biomarker panel that will further be studied for its pathogenic, prognostic and theranostic (diagnostic capability to determine the appropriate treatment for a patient) relevance in spinal cord injury.

 

For this project, blood samples (plasma, serum, freezing/buffy coat) will be collected from patients with both traumatic and pathological spinal cord injury. The results will be correlated with clinical data from the patients with spinal cord injury.